Insufficient scRNA-seq data for expression of RAET1G at single-cell level.
Insufficient scRNA-seq data for expression of RAET1G at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 513.36 | 258 / 258 | 72% | 10.02 | 165 / 230 |
thymus | 94% | 35.52 | 611 / 653 | 75% | 3.00 | 452 / 605 |
uterus | 83% | 36.75 | 141 / 170 | 73% | 7.53 | 335 / 459 |
bladder | 81% | 91.24 | 17 / 21 | 65% | 6.02 | 327 / 504 |
esophagus | 73% | 283.10 | 1059 / 1445 | 63% | 5.06 | 116 / 183 |
lung | 86% | 35.98 | 498 / 578 | 44% | 1.99 | 510 / 1155 |
prostate | 93% | 46.40 | 227 / 245 | 35% | 0.54 | 177 / 502 |
breast | 91% | 37.90 | 418 / 459 | 24% | 0.56 | 269 / 1118 |
skin | 99% | 95.18 | 1799 / 1809 | 13% | 0.37 | 62 / 472 |
brain | 67% | 16.97 | 1773 / 2642 | 43% | 0.74 | 300 / 705 |
kidney | 79% | 29.12 | 70 / 89 | 30% | 0.53 | 274 / 901 |
ovary | 95% | 37.19 | 171 / 180 | 8% | 0.14 | 36 / 430 |
adipose | 85% | 84.49 | 1020 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 6.96 | 35 / 45 |
intestine | 47% | 12.99 | 452 / 966 | 24% | 0.78 | 124 / 527 |
stomach | 44% | 13.27 | 157 / 359 | 22% | 0.43 | 62 / 286 |
blood vessel | 62% | 17.04 | 831 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 15% | 2.61 | 49 / 328 | 39% | 1.31 | 69 / 178 |
heart | 48% | 15.97 | 414 / 861 | 0% | 0 | 0 / 0 |
spleen | 22% | 4.20 | 53 / 241 | 0% | 0 | 0 / 0 |
muscle | 19% | 4.61 | 156 / 803 | 0% | 0 | 0 / 0 |
liver | 10% | 2.95 | 22 / 226 | 3% | 0.08 | 13 / 406 |
peripheral blood | 1% | 0.36 | 9 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0002729 | Biological process | positive regulation of natural killer cell cytokine production |
GO_0002476 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class Ib |
GO_0002486 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent |
GO_0001916 | Biological process | positive regulation of T cell mediated cytotoxicity |
GO_0042267 | Biological process | natural killer cell mediated cytotoxicity |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0046703 | Molecular function | natural killer cell lectin-like receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RAET1G |
Protein name | UL-16 binding protein 5 (Retinoic acid early transcript 1G protein) Retinoic acid early transcript 1G |
Synonyms | ULBP5 |
Description | FUNCTION: [Isoform 1]: Binds and activates the KLRK1/NKG2D receptor, mediating natural killer cell cytotoxicity. .; FUNCTION: [Isoform 3]: Down-regulates the expression of KLRK1 and stimulates natural killer cells to secrete IFNG. .; FUNCTION: [Isoform 2]: Stimulates natural killer cells to secrete IFNG. . |
Accessions | J7HHG3 Q4V753 ENST00000479265.1 J7HBB6 ENST00000367361.6 [Q6H3X3-2] ENST00000367360.7 [Q6H3X3-1] J7HEM2 Q6H3X3 C9JAK3 Q4V9S8 |